Core Points - The stock of Chenxin Pharmaceutical (603367) reached its daily limit, with a turnover rate of 5.97% and a transaction amount of 696 million yuan, showing a fluctuation of 9.62% [2] - Institutional investors net bought 116 million yuan, while the Shanghai Stock Connect saw a net sell of 54.72 million yuan [2] - The stock was listed on the Shanghai Stock Exchange due to a price deviation of 11.18% [2] Trading Data - The top five trading departments had a total transaction amount of 357 million yuan, with a net buying amount of 51.83 million yuan [2] - The first and fourth buying positions were occupied by institutional special seats, collectively net buying 116 million yuan [2] - The Shanghai Stock Connect was the second-largest buying department and the largest selling department, with buying and selling amounts of 52.04 million yuan and 107 million yuan, respectively [2] Fund Flow - The stock experienced a net inflow of 87.10 million yuan from major funds, with a net inflow of 63.80 million yuan from large orders [2] - Over the past five days, the stock saw a net outflow of 115 million yuan from major funds [2] Financial Performance - In the first half of the year, the company reported a revenue of 1.74 billion yuan, a year-on-year decrease of 15.97%, and a net profit of 229 million yuan, down 15.23% year-on-year [3]
辰欣药业9月3日龙虎榜数据